Is Shopify Stock a Good Buy Now?
eCommerce technology platform Shopify (NASDAQ:SHOP) delivered impressive returns in 2025…
Sell
40
SENS Quote, Financials, Valuation and Earnings
Last price:
$7.21
Seasonality move
:
65.68%
Day range:
$7.02 - $7.43
52-week range:
$5.25 - $28.00
Dividend yield:
0%
P/E ratio:
--
P/S ratio:
86.24x
P/B ratio:
3.77x
Volume:
421.8K
Avg. volume:
412.5K
1-year change:
-16.12%
Market cap:
$294.6M
Revenue:
$22.5M
EPS (TTM):
-$1.33
Price Performance History
Performance vs. Valuation Benchmarks
SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS
GET BETTER TRADE IDEAS
Competitors
| Company | Revenue Forecast | Earnings Forecast | Revenue Growth Forecast | Earnings Growth Forecast | Analyst Price Target Median |
|---|---|---|---|---|---|
|
SENS
Senseonics Holdings, Inc.
|
$14.2M | -$0.44 | 48.54% | -2587.58% | $18.92 |
|
BSX
Boston Scientific Corp.
|
$5.3B | $0.78 | 11.5% | 76.25% | $125.45 |
|
DXCM
DexCom, Inc.
|
$1.2B | $0.64 | 11.43% | 70.31% | $85.35 |
|
INSP
Inspire Medical Systems, Inc.
|
$262.3M | $0.67 | 9.42% | -41.59% | $137.31 |
|
PODD
Insulet Corp.
|
$768.3M | $1.46 | 28.59% | 5.4% | $375.60 |
|
TNDM
Tandem Diabetes Care, Inc.
|
$277.1M | -$0.09 | -2.02% | -4.07% | $25.57 |
| Company | Price | Analyst Target | Market Cap | P/E Ratio | Dividend per Share | Dividend Yield | Price / LTM Sales |
|---|---|---|---|---|---|---|---|
|
SENS
Senseonics Holdings, Inc.
|
$7.22 | $18.92 | $294.6M | -- | $0.00 | 0% | 86.24x |
|
BSX
Boston Scientific Corp.
|
$97.64 | $125.45 | $144.7B | 52.23x | $0.00 | 0% | 7.53x |
|
DXCM
DexCom, Inc.
|
$67.40 | $85.35 | $26.3B | 37.51x | $0.00 | 0% | 6.08x |
|
INSP
Inspire Medical Systems, Inc.
|
$98.38 | $137.31 | $2.9B | 67.48x | $0.00 | 0% | 3.35x |
|
PODD
Insulet Corp.
|
$289.04 | $375.60 | $20.3B | 83.86x | $0.00 | 0% | 8.30x |
|
TNDM
Tandem Diabetes Care, Inc.
|
$21.70 | $25.57 | $1.5B | -- | $0.00 | 0% | 1.44x |
| Company | Total Debt / Total Capital | Beta | Debt to Equity | Quick Ratio |
|---|---|---|---|---|
|
SENS
Senseonics Holdings, Inc.
|
34.5% | 0.891 | 11.59% | 5.67x |
|
BSX
Boston Scientific Corp.
|
33.99% | 0.384 | 8.31% | 0.81x |
|
DXCM
DexCom, Inc.
|
48.58% | 1.837 | 9.81% | 1.33x |
|
INSP
Inspire Medical Systems, Inc.
|
4.66% | -0.753 | 1.51% | 3.89x |
|
PODD
Insulet Corp.
|
42.7% | 1.571 | 4.75% | 1.89x |
|
TNDM
Tandem Diabetes Care, Inc.
|
77.16% | 1.942 | 54.61% | 1.79x |
| Company | Gross Profit | Operating Income | Return on Invested Capital | Return on Common Equity | EBIT Margin | Free Cash Flow |
|---|---|---|---|---|---|---|
|
SENS
Senseonics Holdings, Inc.
|
$3.5M | -$19.6M | -64.5% | -127.71% | -242.14% | -$16.4M |
|
BSX
Boston Scientific Corp.
|
$3.3B | $1B | 8.19% | 12.46% | 20.55% | $1.2B |
|
DXCM
DexCom, Inc.
|
$747.4M | $242.5M | 14.67% | 30.94% | 20.05% | $579.4M |
|
INSP
Inspire Medical Systems, Inc.
|
$192.7M | $9.6M | 6.32% | 6.62% | 4.3% | $58.1M |
|
PODD
Insulet Corp.
|
$513.5M | $117.7M | 9.14% | 18.92% | 16.66% | $94.6M |
|
TNDM
Tandem Diabetes Care, Inc.
|
$134.3M | -$20.1M | -31.16% | -110.24% | -8.05% | $4.2M |
Senseonics Holdings, Inc. vs. Competitors
-
Which has Higher Returns SENS or BSX?
Boston Scientific Corp. has a net margin of -241.26% compared to Senseonics Holdings, Inc.'s net margin of 14.91%. Senseonics Holdings, Inc.'s return on equity of -127.71% beat Boston Scientific Corp.'s return on equity of 12.46%.
Company Gross Margin Earnings Per Share Invested Capital SENSSenseonics Holdings, Inc.42.84% -$0.43 $119.3M BSXBoston Scientific Corp.65.31% $0.50 $35.7B -
What do Analysts Say About SENS or BSX?
Senseonics Holdings, Inc. has a consensus price target of $18.92, signalling upside risk potential of 162%. On the other hand Boston Scientific Corp. has an analysts' consensus of $125.45 which suggests that it could grow by 28.48%. Given that Senseonics Holdings, Inc. has higher upside potential than Boston Scientific Corp., analysts believe Senseonics Holdings, Inc. is more attractive than Boston Scientific Corp..
Company Buy Ratings Hold Ratings Sell Ratings SENSSenseonics Holdings, Inc.4 2 0 BSXBoston Scientific Corp.25 2 0 -
Is SENS or BSX More Risky?
Senseonics Holdings, Inc. has a beta of 0.636, which suggesting that the stock is 36.416% less volatile than S&P 500. In comparison Boston Scientific Corp. has a beta of 0.670, suggesting its less volatile than the S&P 500 by 33.029%.
-
Which is a Better Dividend Stock SENS or BSX?
Senseonics Holdings, Inc. has a quarterly dividend of $0.00 per share corresponding to a yield of 0%. Boston Scientific Corp. offers a yield of 0% to investors and pays a quarterly dividend of $0.00 per share. Senseonics Holdings, Inc. pays -- of its earnings as a dividend. Boston Scientific Corp. pays out -- of its earnings as a dividend.
-
Which has Better Financial Ratios SENS or BSX?
Senseonics Holdings, Inc. quarterly revenues are $8.1M, which are smaller than Boston Scientific Corp. quarterly revenues of $5.1B. Senseonics Holdings, Inc.'s net income of -$19.5M is lower than Boston Scientific Corp.'s net income of $755M. Notably, Senseonics Holdings, Inc.'s price-to-earnings ratio is -- while Boston Scientific Corp.'s PE ratio is 52.23x. Generally a lower price-to-earnings ratio signals a stock is trading at a lower multiple of earnings and is a better value. Another key metric is the price-to-sales ratio, which for Senseonics Holdings, Inc. is 86.24x versus 7.53x for Boston Scientific Corp.. Usually stocks with elevated PS ratios are considered overvalued.
Company Price/Sales Ratio Price/Earnings Ratio Quarterly Revenue Quarterly Net Income SENSSenseonics Holdings, Inc.86.24x -- $8.1M -$19.5M BSXBoston Scientific Corp.7.53x 52.23x $5.1B $755M
-
Which has Higher Returns SENS or DXCM?
DexCom, Inc. has a net margin of -241.26% compared to Senseonics Holdings, Inc.'s net margin of 23.47%. Senseonics Holdings, Inc.'s return on equity of -127.71% beat DexCom, Inc.'s return on equity of 30.94%.
Company Gross Margin Earnings Per Share Invested Capital SENSSenseonics Holdings, Inc.42.84% -$0.43 $119.3M DXCMDexCom, Inc.61.8% $0.70 $5.3B -
What do Analysts Say About SENS or DXCM?
Senseonics Holdings, Inc. has a consensus price target of $18.92, signalling upside risk potential of 162%. On the other hand DexCom, Inc. has an analysts' consensus of $85.35 which suggests that it could grow by 26.63%. Given that Senseonics Holdings, Inc. has higher upside potential than DexCom, Inc., analysts believe Senseonics Holdings, Inc. is more attractive than DexCom, Inc..
Company Buy Ratings Hold Ratings Sell Ratings SENSSenseonics Holdings, Inc.4 2 0 DXCMDexCom, Inc.20 4 0 -
Is SENS or DXCM More Risky?
Senseonics Holdings, Inc. has a beta of 0.636, which suggesting that the stock is 36.416% less volatile than S&P 500. In comparison DexCom, Inc. has a beta of 1.480, suggesting its more volatile than the S&P 500 by 48.047%.
-
Which is a Better Dividend Stock SENS or DXCM?
Senseonics Holdings, Inc. has a quarterly dividend of $0.00 per share corresponding to a yield of 0%. DexCom, Inc. offers a yield of 0% to investors and pays a quarterly dividend of $0.00 per share. Senseonics Holdings, Inc. pays -- of its earnings as a dividend. DexCom, Inc. pays out -- of its earnings as a dividend.
-
Which has Better Financial Ratios SENS or DXCM?
Senseonics Holdings, Inc. quarterly revenues are $8.1M, which are smaller than DexCom, Inc. quarterly revenues of $1.2B. Senseonics Holdings, Inc.'s net income of -$19.5M is lower than DexCom, Inc.'s net income of $283.8M. Notably, Senseonics Holdings, Inc.'s price-to-earnings ratio is -- while DexCom, Inc.'s PE ratio is 37.51x. Generally a lower price-to-earnings ratio signals a stock is trading at a lower multiple of earnings and is a better value. Another key metric is the price-to-sales ratio, which for Senseonics Holdings, Inc. is 86.24x versus 6.08x for DexCom, Inc.. Usually stocks with elevated PS ratios are considered overvalued.
Company Price/Sales Ratio Price/Earnings Ratio Quarterly Revenue Quarterly Net Income SENSSenseonics Holdings, Inc.86.24x -- $8.1M -$19.5M DXCMDexCom, Inc.6.08x 37.51x $1.2B $283.8M
-
Which has Higher Returns SENS or INSP?
Inspire Medical Systems, Inc. has a net margin of -241.26% compared to Senseonics Holdings, Inc.'s net margin of 4.42%. Senseonics Holdings, Inc.'s return on equity of -127.71% beat Inspire Medical Systems, Inc.'s return on equity of 6.62%.
Company Gross Margin Earnings Per Share Invested Capital SENSSenseonics Holdings, Inc.42.84% -$0.43 $119.3M INSPInspire Medical Systems, Inc.85.85% $0.34 $699M -
What do Analysts Say About SENS or INSP?
Senseonics Holdings, Inc. has a consensus price target of $18.92, signalling upside risk potential of 162%. On the other hand Inspire Medical Systems, Inc. has an analysts' consensus of $137.31 which suggests that it could grow by 39.57%. Given that Senseonics Holdings, Inc. has higher upside potential than Inspire Medical Systems, Inc., analysts believe Senseonics Holdings, Inc. is more attractive than Inspire Medical Systems, Inc..
Company Buy Ratings Hold Ratings Sell Ratings SENSSenseonics Holdings, Inc.4 2 0 INSPInspire Medical Systems, Inc.9 6 0 -
Is SENS or INSP More Risky?
Senseonics Holdings, Inc. has a beta of 0.636, which suggesting that the stock is 36.416% less volatile than S&P 500. In comparison Inspire Medical Systems, Inc. has a beta of 0.725, suggesting its less volatile than the S&P 500 by 27.474%.
-
Which is a Better Dividend Stock SENS or INSP?
Senseonics Holdings, Inc. has a quarterly dividend of $0.00 per share corresponding to a yield of 0%. Inspire Medical Systems, Inc. offers a yield of 0% to investors and pays a quarterly dividend of $0.00 per share. Senseonics Holdings, Inc. pays -- of its earnings as a dividend. Inspire Medical Systems, Inc. pays out -- of its earnings as a dividend.
-
Which has Better Financial Ratios SENS or INSP?
Senseonics Holdings, Inc. quarterly revenues are $8.1M, which are smaller than Inspire Medical Systems, Inc. quarterly revenues of $224.5M. Senseonics Holdings, Inc.'s net income of -$19.5M is lower than Inspire Medical Systems, Inc.'s net income of $9.9M. Notably, Senseonics Holdings, Inc.'s price-to-earnings ratio is -- while Inspire Medical Systems, Inc.'s PE ratio is 67.48x. Generally a lower price-to-earnings ratio signals a stock is trading at a lower multiple of earnings and is a better value. Another key metric is the price-to-sales ratio, which for Senseonics Holdings, Inc. is 86.24x versus 3.35x for Inspire Medical Systems, Inc.. Usually stocks with elevated PS ratios are considered overvalued.
Company Price/Sales Ratio Price/Earnings Ratio Quarterly Revenue Quarterly Net Income SENSSenseonics Holdings, Inc.86.24x -- $8.1M -$19.5M INSPInspire Medical Systems, Inc.3.35x 67.48x $224.5M $9.9M
-
Which has Higher Returns SENS or PODD?
Insulet Corp. has a net margin of -241.26% compared to Senseonics Holdings, Inc.'s net margin of 12.4%. Senseonics Holdings, Inc.'s return on equity of -127.71% beat Insulet Corp.'s return on equity of 18.92%.
Company Gross Margin Earnings Per Share Invested Capital SENSSenseonics Holdings, Inc.42.84% -$0.43 $119.3M PODDInsulet Corp.72.7% $1.24 $2.4B -
What do Analysts Say About SENS or PODD?
Senseonics Holdings, Inc. has a consensus price target of $18.92, signalling upside risk potential of 162%. On the other hand Insulet Corp. has an analysts' consensus of $375.60 which suggests that it could grow by 29.95%. Given that Senseonics Holdings, Inc. has higher upside potential than Insulet Corp., analysts believe Senseonics Holdings, Inc. is more attractive than Insulet Corp..
Company Buy Ratings Hold Ratings Sell Ratings SENSSenseonics Holdings, Inc.4 2 0 PODDInsulet Corp.19 2 0 -
Is SENS or PODD More Risky?
Senseonics Holdings, Inc. has a beta of 0.636, which suggesting that the stock is 36.416% less volatile than S&P 500. In comparison Insulet Corp. has a beta of 1.400, suggesting its more volatile than the S&P 500 by 39.975%.
-
Which is a Better Dividend Stock SENS or PODD?
Senseonics Holdings, Inc. has a quarterly dividend of $0.00 per share corresponding to a yield of 0%. Insulet Corp. offers a yield of 0% to investors and pays a quarterly dividend of $0.00 per share. Senseonics Holdings, Inc. pays -- of its earnings as a dividend. Insulet Corp. pays out -- of its earnings as a dividend.
-
Which has Better Financial Ratios SENS or PODD?
Senseonics Holdings, Inc. quarterly revenues are $8.1M, which are smaller than Insulet Corp. quarterly revenues of $706.3M. Senseonics Holdings, Inc.'s net income of -$19.5M is lower than Insulet Corp.'s net income of $87.6M. Notably, Senseonics Holdings, Inc.'s price-to-earnings ratio is -- while Insulet Corp.'s PE ratio is 83.86x. Generally a lower price-to-earnings ratio signals a stock is trading at a lower multiple of earnings and is a better value. Another key metric is the price-to-sales ratio, which for Senseonics Holdings, Inc. is 86.24x versus 8.30x for Insulet Corp.. Usually stocks with elevated PS ratios are considered overvalued.
Company Price/Sales Ratio Price/Earnings Ratio Quarterly Revenue Quarterly Net Income SENSSenseonics Holdings, Inc.86.24x -- $8.1M -$19.5M PODDInsulet Corp.8.30x 83.86x $706.3M $87.6M
-
Which has Higher Returns SENS or TNDM?
Tandem Diabetes Care, Inc. has a net margin of -241.26% compared to Senseonics Holdings, Inc.'s net margin of -8.49%. Senseonics Holdings, Inc.'s return on equity of -127.71% beat Tandem Diabetes Care, Inc.'s return on equity of -110.24%.
Company Gross Margin Earnings Per Share Invested Capital SENSSenseonics Holdings, Inc.42.84% -$0.43 $119.3M TNDMTandem Diabetes Care, Inc.53.88% -$0.31 $582.2M -
What do Analysts Say About SENS or TNDM?
Senseonics Holdings, Inc. has a consensus price target of $18.92, signalling upside risk potential of 162%. On the other hand Tandem Diabetes Care, Inc. has an analysts' consensus of $25.57 which suggests that it could grow by 17.84%. Given that Senseonics Holdings, Inc. has higher upside potential than Tandem Diabetes Care, Inc., analysts believe Senseonics Holdings, Inc. is more attractive than Tandem Diabetes Care, Inc..
Company Buy Ratings Hold Ratings Sell Ratings SENSSenseonics Holdings, Inc.4 2 0 TNDMTandem Diabetes Care, Inc.7 13 0 -
Is SENS or TNDM More Risky?
Senseonics Holdings, Inc. has a beta of 0.636, which suggesting that the stock is 36.416% less volatile than S&P 500. In comparison Tandem Diabetes Care, Inc. has a beta of 1.682, suggesting its more volatile than the S&P 500 by 68.218%.
-
Which is a Better Dividend Stock SENS or TNDM?
Senseonics Holdings, Inc. has a quarterly dividend of $0.00 per share corresponding to a yield of 0%. Tandem Diabetes Care, Inc. offers a yield of 0% to investors and pays a quarterly dividend of $0.00 per share. Senseonics Holdings, Inc. pays -- of its earnings as a dividend. Tandem Diabetes Care, Inc. pays out -- of its earnings as a dividend.
-
Which has Better Financial Ratios SENS or TNDM?
Senseonics Holdings, Inc. quarterly revenues are $8.1M, which are smaller than Tandem Diabetes Care, Inc. quarterly revenues of $249.3M. Senseonics Holdings, Inc.'s net income of -$19.5M is higher than Tandem Diabetes Care, Inc.'s net income of -$21.2M. Notably, Senseonics Holdings, Inc.'s price-to-earnings ratio is -- while Tandem Diabetes Care, Inc.'s PE ratio is --. Generally a lower price-to-earnings ratio signals a stock is trading at a lower multiple of earnings and is a better value. Another key metric is the price-to-sales ratio, which for Senseonics Holdings, Inc. is 86.24x versus 1.44x for Tandem Diabetes Care, Inc.. Usually stocks with elevated PS ratios are considered overvalued.
Company Price/Sales Ratio Price/Earnings Ratio Quarterly Revenue Quarterly Net Income SENSSenseonics Holdings, Inc.86.24x -- $8.1M -$19.5M TNDMTandem Diabetes Care, Inc.1.44x -- $249.3M -$21.2M
SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS
GET BETTER TRADE IDEAS
Popular
Will The Magnificent 7 Stocks Go Up This Year?
2025 was another banner year for the Magnificent Seven stocks,…
Why Did Planet Labs Stock Rally So Much?
Satellite imaging startup Planet Labs (NYSE:PL), after years of disappointing…
Stock Ideas
Buy
52
Is NVDA Stock a Buy?
Market Cap: $4.5T
P/E Ratio: 63x
Buy
65
Is GOOG Stock a Buy?
Market Cap: $4T
P/E Ratio: 41x
Buy
51
Is GOOGL Stock a Buy?
Market Cap: $4T
P/E Ratio: 41x
Alerts
Buy
100
ATGL alert for Jan 10
Alpha Technology Group Ltd. [ATGL] is up 47.05% over the past day.
Buy
71
NAIL alert for Jan 10
Direxion Daily Homebuilders & Supplies Bull 3X Shs [NAIL] is up 18.52% over the past day.
Buy
54
LGIH alert for Jan 10
LGI Homes, Inc. [LGIH] is up 13.81% over the past day.
